Significance of MYCN Amplification in International Neuroblastoma Staging System Stage 1 and 2 Neuroblastoma: A Report From the International Neuroblastoma Risk Group Database

PURPOSE: Treatment of patients with localized neuroblastoma with unfavorable biologic features is controversial. To evaluate the outcome of children with low-stage MYCN-amplified neuroblastoma and develop a rational treatment strategy, data from the International Neuroblastoma Risk Group (INRG) data...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Bagatell, Rochelle, Beck-Popovic, Maja, London, Wendy B., Zhang, Yang, Pearson, Andrew D.J., Matthay, Katherine K., Monclair, Tom, Ambros, Peter F., Cohn, Susan L.
Format: Artigo
Langue:Inglês
Publié: American Society of Clinical Oncology 2009
Sujets:
Pediatric Oncology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2651034/
https://ncbi.nlm.nih.gov/pubmed/19047282
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.17.9184
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires